VIP: A Drug Target with Potential Health Benefits and Biomarker for Disease

Target Name: VIP

NCBI ID: G7432

Content of Review Report on VIP Target / Biomarker

VIP

VIP: A Drug Target with Potential Health Benefits and Biomarker for Disease

VIP (Vasoactive Intestinal Protagonist) is a drug target and a biomarker that has been shown to play a crucial role in the regulation of blood flow and gut function.VIP has been shown to promote blood vessel growth and stimulate the growth of new blood vessels in the gut, which can lead to improved blood flow and oxygenation of the gut tissues. This increase in blood flow can lead to a variety of potential health benefits, including improved immune function, increased tissue repair and regeneration, and enhanced overall systemic health.

VIP has also been shown to play a role in the regulation of inflammation and immune function. VIP has been shown to reduce inflammation in the gut by suppressing the production of pro-inflammatory cytokines. This can help to reduce the risk of chronic inflammatory diseases, such as inflammatory bowel disease and colitis.

In addition to its potential health benefits, VIP has also been shown to be a valuable biomarker for a number of diseases, including cancer, neurodegenerative diseases, and chronic obstructive pulmonary disease (COPD). VIP has been shown to be elevated in the blood of patients with these conditions, making it a potentially useful diagnostic tool for these diseases.

VIP has also been shown to have potential therapeutic applications in a number of areas, including cancer, neurodegenerative diseases, and cardiovascular disease. For example, VIP has been shown to be effective in slowing the growth of cancer cells and may be a useful target for cancer treatment. Additionally, VIP has been shown to improve blood flow and oxygenation in the brain, which may make it an effective target for neurodegenerative diseases.

In conclusion, VIP is a drug target and biomarker that has the potential to improve a wide range of health outcomes. Further research is needed to fully understand the full range of benefits and risks of VIP, as well as to develop more effective treatments for the conditions that are currently treated with VIP.

Protein Name: Vasoactive Intestinal Peptide

Functions: VIP causes vasodilation, lowers arterial blood pressure, stimulates myocardial contractility, increases glycogenolysis and relaxes the smooth muscle of trachea, stomach and gall bladder

The "VIP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VIP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets